PGRMC1: a new biomarker for the estrogen receptor in breast cancer

Estrogen receptor (ER) status is a critical biomarker in breast cancer, in large part because the ER is the target of tamoxifen and similar drugs. In the previous issue of Breast Cancer Research, Neubauer and colleagues used a proteomic approach to identify proteins that are differentially regulated...

Descripción completa

Detalles Bibliográficos
Autor principal: Craven, Rolf J
Formato: Texto
Lenguaje:English
Publicado: BioMed Central 2008
Materias:
Editorial
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2656908/
https://www.ncbi.nlm.nih.gov/pubmed/19090968
http://dx.doi.org/10.1186/bcr2191

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2656908/
https://www.ncbi.nlm.nih.gov/pubmed/19090968
http://dx.doi.org/10.1186/bcr2191

Ejemplares similares